LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 233 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $258,000 | -14.9% | 2,383 | -20.7% | 0.02% | -6.2% |
| Q2 2015 | $303,000 | +30.6% | 3,004 | 0.0% | 0.02% | +33.3% |
| Q1 2015 | $232,000 | -41.7% | 3,004 | -59.8% | 0.01% | -45.5% |
| Q4 2014 | $398,000 | +13.4% | 7,476 | 0.0% | 0.02% | +10.0% |
| Q3 2014 | $351,000 | -24.7% | 7,476 | 0.0% | 0.02% | -23.1% |
| Q2 2014 | $466,000 | +129.6% | 7,476 | +148.1% | 0.03% | +116.7% |
| Q1 2014 | $203,000 | -76.6% | 3,013 | -81.7% | 0.01% | -72.7% |
| Q4 2013 | $867,000 | +21.6% | 16,484 | 0.0% | 0.04% | +7.3% |
| Q3 2013 | $713,000 | -15.2% | 16,484 | -26.7% | 0.04% | -19.6% |
| Q2 2013 | $841,000 | – | 22,496 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |